Venofer 20 mg Fe / ml Injektionslösung Konzentrat zur Herstellung einer Injektionslösung oder Infusionslösung Ujerumani - Kijerumani - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

venofer 20 mg fe / ml injektionslösung konzentrat zur herstellung einer injektionslösung oder infusionslösung

vifor france - eisen(iii)-hydroxid-sucrose-wasser-komplex - konzentrat zur herstellung einer injektionslösung oder infusionslösung - eisen(iii)-hydroxid-sucrose-wasser-komplex 2700.mg

Venofer 20 mg Fe / ml Injektionslösung Konzentrat zur Herstellung einer Injektionslösung oder Infusionslösung Ujerumani - Kijerumani - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

venofer 20 mg fe / ml injektionslösung konzentrat zur herstellung einer injektionslösung oder infusionslösung

vifor france - eisen(iii)-hydroxid-sucrose-wasser-komplex - konzentrat zur herstellung einer injektionslösung oder infusionslösung - eisen(iii)-hydroxid-sucrose-wasser-komplex 2700.mg

VENOFER- iron sucrose injection, solution Marekani - Kiingereza - NLM (National Library of Medicine)

venofer- iron sucrose injection, solution

a-s medication solutions - iron sucrose (unii: fz7nyf5n8l) (ferric cation - unii:91o4lml611) - venofer is indicated for the treatment of iron deficiency anemia (ida) in patients with chronic kidney disease (ckd). - known hypersensitivity to venofer. risk summary published studies on intravenous iron sucrose treatment after the first trimester of pregnancy have not shown adverse maternal or fetal outcomes (see data) . available reports of intravenous iron sucrose use in pregnant women during the first trimester are insufficient to assess the risk of major birth defects and miscarriage. there are risks to the mother and fetus associated with untreated ida in pregnancy as well as risks to the fetus associated with maternal severe hypersensitivity reactions (see clinical considerations) . animal reproduction studies of iron sucrose administered to rats and rabbits during the period of organogenesis at elemental iron doses equivalent to the maximum recommended human dose based on body surface area revealed no evidence of harm to the fetus (see data). the estimated background risk of major birth defects and

Venofer 20 mg iron/mL solution for injection or concentrate for solution for infusion, ampoule Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

venofer 20 mg iron/ml solution for injection or concentrate for solution for infusion, ampoule

vifor france - iron (iii) - solution for injection/infusion - 20 milligram(s)/millilitre - iron trivalent, oral preparations; saccharated iron oxide

Venofer 20 mg iron/mL solution for injection or concentrate for solution for infusion, vial Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

venofer 20 mg iron/ml solution for injection or concentrate for solution for infusion, vial

vifor france - iron (iii) - hydroxide sucrose complex - solution for injection/infusion - 20  milligram(s)/millilitre - iron trivalent, oral preparations; saccharated iron oxide

Venofer 100mg / 5 ml Soluzione iniettabile Uswisi - Kiitaliano - Swissmedic (Swiss Agency for Therapeutic Products)

venofer 100mg / 5 ml soluzione iniettabile

vifor (international) inc. - ferro(iii) - soluzione iniettabile - ferrum(iii) 100 mg ut ferri oxidum saccharatum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile ad solutionem pro 5 ml corresp. natrium max 7 mg/ml. - anemia da carenza di ferro in caso di accertata carenza di ferro, quando la terapia orale non è fattibile - synthetika